drugset
drugset / Trial / NCT00609609

Photopheresis for the Treatment of Acute Graft Versus Host Disease

NCT00609609 ↗

Phase 2 Completed 81 enrolled M.D. Anderson Cancer Center Mallinckrodt · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical research study is to find out whether adding extracorporeal photopheresis (ECP) to standard therapy for acute GVHD with corticosteroids improves response to treatment, length of treatment, and survival.

Timeline

Start
2008-01
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Background Methylprednisolone Other / unclassified 2 mg/kg —

Indications

acute graft versus host disease